Steven Ryder

Steven Ryder

Chief Tech/Sci/R&D Officer at RALLYBIO CORPORATION

Net worth: 317 411 $ as of 30/04/2024

73 year
Health Technology
Commercial Services
Consumer Services

Profile

Steven W.
Ryder
is currently a Director at Biotechnology Innovation Organization, Director at Levo Therapeutics, Inc., and Chief Medical Officer at Rallybio Corp.
Previously, he served as an Independent Director at Reata Pharmaceuticals, Inc. from 2022 to 2023, Chief Development Officer at Alexion Pharmaceuticals, Inc. from 2013 to 2018, President at American Society of Clinical Psychopharmacology, and President at Astellas Pharma Global Development, Inc. from 2008 to 2013.
He holds a doctorate degree from Icahn School of Medicine at Mount Sinai.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2024 192,370 ( 0.51% ) 317 411 $ 30/04/2024

Steven Ryder active positions

CompaniesPositionStart
RALLYBIO CORPORATION Chief Tech/Sci/R&D Officer 01/01/2019
Director/Board Member -
Director/Board Member 01/07/2019
All active positions of Steven Ryder

Former positions of Steven Ryder

CompaniesPositionEnd
REATA PHARMACEUTICALS, INC. Director/Board Member 26/09/2023
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/12/2018
President 01/04/2013
American Society of Clinical Psychopharmacology President -
See the detail of Steven Ryder's experience

Training of Steven Ryder

Icahn School of Medicine at Mount Sinai Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven Ryder's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
RALLYBIO CORPORATION

Health Technology

Private companies6

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

American Society of Clinical Psychopharmacology

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW